In Brief: Cytogen's Quadramet
Executive Summary
Cytogen's Quadramet: Company submits NDA for Quadramet (samarium-EDTMP) for the treatment of "severe and chronic pain associated with cancer that spreads to the bone." DuPont Merck will manufacture and market the product in the U.S...